In the context of the international collaboration recently started between LABION (Fondazione Don Gnocchi) and “Nanotherapy and Nanodiagnostic Group” (CSIC – University of Zaragoza), Dr. Jesus M. de la Fuente will give a seminar entitled “Nanoparticles for diagnosis and therapy” at Fondazione Don Gnocchi, on Tuesday 22nd September, 12.30 a.m., Sala Cardini.
Dr. Jesus M. de la Fuente finished his PhD work in 2003 working in the evaluation of carbohydrate-carbohydrate interactions using gold nanoparticles in the Institute of Chemical Research from CSIC. During his PhD training, he has carried out different stays in the University of Nottingham (UK), University of Kalmar (Sweden), Institute of Physical-Chemistry “Rocasolano”-CSIC (Madrid, Spain) and National Centre of Biotechnology-CSIC (Madrid, Spain). With all this research, he was a pioneer in the emerging field of Glyconanotechnology. Once he obtained his PhD, he moved to the Centre for Cell Engineering University of Glasgow (UK) to develop a research project involving the nanoparticles development and its biological application during two years. In July 2005, he went back to the Institute of Chemical Research (Seville, Spain). His research was oriented to the vectorization of paramagnetic nanoparticles with biologically relevant carbohydrates to label and visualize brain tumors.
In June 2007, Dr de la Fuente established the Nanotherapy and Nanodiagnostic Group at the Institute of Nanoscience of Aragon (University of Zaragoza, Spain). Dr. de la Fuente has supervised 12 PhD students (to completion) and he is presently supervising 5 PhD students. Since then, Dr de la Fuente has created a large research group with outstanding scientific results and excellence research projects. He has been coordinator of one Marie Curie IOF and four Marie Curie IEF fellows. As principle investigator he has received a European Research Council Starting Grant for “Multifunctional Magnetic Nanoparticles: Towards Smart Drugs Design-NANOPUZZLE” worth 1.541.000€ (2010-2015), and ERANET project “Multifunctional Gold Nanoparticles for Gene-Therapy-NANOTRUCK” (2009-2012) and he is co-PI of a FP7-NMP “Nanotherapeutics for Antibiotic Resistant Emerging Bacterial Pathogens-NAREB” (2014-2018). He has actually 5 licensed PCT patents and he has been promoter of the spin-out company Nanoimmunotech S.L. To date, he has more than 120 papers, cited more than 3,100 times and with an h-factor of 30. Since 2003, he is associate member of the Centre for Cell Engineering at the University of Glasgow (UK), and he was awarded with the “Shanghai-1000 People Plan” in 2013 to be Visitor Professor at Jiao Tong University (Shanghai, China). Since 2014, he is a Permanent Researcher at the Spanish National Research Council- Aragon Materials Science Institute (Zaragoza, Spain)
